Next week's Stock Market Outlook: Key Releases and Insights
The stock market is abuzz with a plethora of releases from major companies, offering a glimpse into their financial health and future prospects. Here's a breakdown of what to expect from a selection of FTSE 100, FTSE 250, and other notable companies reporting next week, starting February 9, 2026.
February 9, 2026:
- HgCapital Trust: Full Year Trading Update - Investors will be keen to hear about the trust's performance and any strategic updates.
- Plus500: Full Year Results - This company's performance in the past year and its outlook will be under scrutiny.
February 10, 2026:
- AstraZeneca: Full Year Results - AstraZeneca's strong momentum in the third quarter and its confidence in reaching 2030 revenue targets will be in focus. Analysts will be watching for reassurance on future targets and potential for stronger-than-expected results.
- Barclays: Full Year Results - Barclays' financial performance and strategic initiatives will be analyzed.
- Bellway: Trading Update - Bellway's sales and completions will be scrutinized, especially in the context of affordability issues.
- BP: Full Year Results - BP's financial performance and strategic updates will be of interest.
- Coca-Cola: Q4 Results - Coca-Cola's quarterly performance and its ability to navigate market challenges will be key.
- Coca-Cola HBC: Q4 Results - Similar to its parent company, Coca-Cola HBC's Q4 performance will be analyzed.
- Dunelm: Half Year Results - Dunelm's half-year performance and its strategy for the year ahead will be of interest.
- TSMC: Corporate Sales Release - TSMC's sales performance and its impact on the semiconductor industry will be highlighted.
- TUI: Q1 Results - TUI's Q1 performance and its outlook for the year will be under the microscope.
February 11, 2026:
- Barratt Redrow: Half Year Results - Barratt Redrow's strong start to the financial year and its ability to meet full-year guidance will be crucial. Affordability issues and demand will be key areas of focus.
- Renishaw: Half Year Results - Renishaw's performance and strategic initiatives will be analyzed.
- Shopify: Q4 Results - Shopify's Q4 performance and its e-commerce platform's growth will be of interest.
February 12, 2026:
- Ashmore Group: Half Year Results - Ashmore Group's performance and its strategy for the year ahead will be scrutinized.
- British American Tobacco: Full Year Results - British American Tobacco's financial performance and strategic updates will be analyzed.
- RELX: Full Year Results - RELX's performance and its focus on sustainability will be of interest.
- Schroders: Full Year Results - Schroders' financial performance and its investment strategies will be under the spotlight.
- Unilever: Full Year Results - Unilever's recent strong performance and the impact of its ice cream demerger will be analyzed. The outlook for 2026 and its sales growth target will be crucial.
February 13, 2026:
- Cameco: Q4 Results - Cameco's Q4 performance and its nuclear energy operations will be highlighted.
- NatWest: Full Year Results - NatWest's financial performance and strategic initiatives will be analyzed.
Note: This article highlights companies we will be updating investors on.
Key Takeaways and Insights:
- AstraZeneca's strong momentum and confidence in 2030 targets are positive signs, but analysts remain cautious.
- Barratt Redrow's strong start and focus on affordability are crucial for its full-year guidance.
- Unilever's demerger and streamlining efforts will impact its sales and profits, with a focus on 2026 sales growth.
Remember, this article is for informational purposes only and should not be considered personal financial advice. Always consult a professional before making investment decisions.
